Thomas A B Sanders1, Sarah E E Berry, George J Miller. 1. Department of Nutrition & Dietetics, Nutrition Food and Health Research Centre, King's College London, United Kingdom. tom.sanders@kcl.ac.uk
Abstract
BACKGROUND: The consumption of a synthetic, randomized, stearic acid-rich triacylglycerol results in decreased postprandial lipemia and activated factor VII (FVII:a) compared with cocoa butter (a nonrandomized, symmetrical, stearic acid-rich triacylglycerol). It was hypothesized that this difference is a consequence of the differences in structure between the 2 triacylglycerols. OBJECTIVE: The objective was to test whether the consumption of randomized cocoa butter decreases postprandial lipemia and FVII:a. DESIGN: A randomized crossover trial with 17 male subjects compared the effects of meals containing 50 g fat provided as a symmetrical (cocoa butter) or an asymmetrical (randomized cocoa butter) triacylglycerol on postprandial changes in lipids, chylomicron composition, and FVII:a. RESULTS: After randomization, the postprandial area under the curve for plasma triacylglycerol decreased by 41% (P < 0.01). At 3 h the plasma concentrations of triacylglycerol, palmitic acid, stearic acid, and oleic acid were 26%, 18%, 34%, and 19% lower, respectively. The proportion of oleic acid in the sn-2 position of the chylomicron triacylglycerol was reduced from 67.4 mol% to 35.9 mol% and resulted in an increase in the proportion of stearic acid in the sn-2 position from 9.2 mol% to 25.4 mol%. FVII:a did not increase 6 h after consumption of the randomized cocoa butter (: 1.2; 95% CI: -2.7, 4.6 U/L) but increased significantly (: 7.7; 95% CI: 2.5,12.9 U/L) 6 h after consumption of the unrandomized cocoa butter. CONCLUSIONS:Symmetrical stearic acid-rich triacylglycerol with oleic acid in the sn-2 position appears to be absorbed more rapidly than is asymmetrical triacylglycerols with long-chain saturated fatty acids in the sn-2 position, which leads to activation of FVII.
RCT Entities:
BACKGROUND: The consumption of a synthetic, randomized, stearic acid-rich triacylglycerol results in decreased postprandial lipemia and activated factor VII (FVII:a) compared with cocoabutter (a nonrandomized, symmetrical, stearic acid-rich triacylglycerol). It was hypothesized that this difference is a consequence of the differences in structure between the 2 triacylglycerols. OBJECTIVE: The objective was to test whether the consumption of randomized cocoabutter decreases postprandial lipemia and FVII:a. DESIGN: A randomized crossover trial with 17 male subjects compared the effects of meals containing 50 g fat provided as a symmetrical (cocoabutter) or an asymmetrical (randomized cocoabutter) triacylglycerol on postprandial changes in lipids, chylomicron composition, and FVII:a. RESULTS: After randomization, the postprandial area under the curve for plasma triacylglycerol decreased by 41% (P < 0.01). At 3 h the plasma concentrations of triacylglycerol, palmitic acid, stearic acid, and oleic acid were 26%, 18%, 34%, and 19% lower, respectively. The proportion of oleic acid in the sn-2 position of the chylomicron triacylglycerol was reduced from 67.4 mol% to 35.9 mol% and resulted in an increase in the proportion of stearic acid in the sn-2 position from 9.2 mol% to 25.4 mol%. FVII:a did not increase 6 h after consumption of the randomized cocoabutter (: 1.2; 95% CI: -2.7, 4.6 U/L) but increased significantly (: 7.7; 95% CI: 2.5,12.9 U/L) 6 h after consumption of the unrandomized cocoabutter. CONCLUSIONS: Symmetrical stearic acid-rich triacylglycerol with oleic acid in the sn-2 position appears to be absorbed more rapidly than is asymmetrical triacylglycerols with long-chain saturated fatty acids in the sn-2 position, which leads to activation of FVII.
Authors: Charlotte E Mills; Scott V Harding; Mariam Bapir; Giuseppina Mandalari; Louise J Salt; Robert Gray; Barbara A Fielding; Peter J Wilde; Wendy L Hall; Sarah E Berry Journal: Am J Clin Nutr Date: 2021-05-08 Impact factor: 7.045
Authors: Sarah E E Berry; Rebecca Woodward; Christabelle Yeoh; George J Miller; Thomas A B Sanders Journal: Lipids Date: 2007-01-31 Impact factor: 1.880
Authors: Wendy L Hall; Marcela Fiuza Brito; Junlan Huang; Lucy V Wood; Androulla Filippou; Thomas A B Sanders; Sarah E E Berry Journal: Lipids Date: 2014-08-08 Impact factor: 1.880
Authors: Ronald P Mensink; Thomas A Sanders; David J Baer; K C Hayes; Philip N Howles; Alejandro Marangoni Journal: Adv Nutr Date: 2016-07-15 Impact factor: 8.701
Authors: Penny M Kris-Etherton; Amy E Griel; Tricia L Psota; Sarah K Gebauer; Jun Zhang; Terry D Etherton Journal: Lipids Date: 2005-12 Impact factor: 1.880